Blood Plasma Market Forecast 2019-2023 Growth Drivers, Regional Outlook

The global blood plasma market is estimated to reach US$29.50 billion in 2023, growing at a CAGR of 7% for the period spanning from 2019 to 2023. The factors such as progress in therapeutic protein development, new advances in production of plasma, growing aging population, increasing spending on medicines and rise in collection centers are expected to drive the market. However, growth of the industry will be challenged by high cost of treatment, and high R&D costs. A few notable trends include increase in fractionation capacity, and innovation in therapeutics.

Components of Blood Plasma: Proteins, Amino Acids, Electrolytes, Nutrients and Gases & Nitrogenous Waste

Get Free Sample PDF Report @

The global blood plasma market is broadly segmented into four types which are Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others. Increased recognition and treatment of primary immunodeficiency (PI), use in new indications, and increasing consumption in low IG-use countries has driven the growth of immunoglobulin segment.

North America is the largest market for blood plasma due to its advanced infrastructure which has helped in increasing plasma collection over the time. The emerging economies like China have showed huge potential with increased imports of Albumin. Rising use of immunoglobulin and increasing incidence of immune and bleeding disorders propelled the demand for immunoglobulin in the Unites States.

Blood Plasma Report Coverage:

  • Introduction/Market Overview
  • Global Market Analysis
  • Regional Market Analysis
  • Market Dynamics –Drivers, Trends & Challenges
  • Competitive Landscape
  • Company Profiles

Scope of the report:

  • The report provides a comprehensive analysis of the global blood plasma market, segmented into Immunoglobulin, Albumin, Factor VIII, Alpha 1 and Others.
  • The major regional markets (North America, Europe and APAC) have been analyzed, along with country coverage of the United States.
  • The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.
  • The competitive landscape of the market, along with the company profiles of leading players (Takeda Pharmaceutical, CSL Limited, Grifols S.A., Octapharma, Inc., ADMA Biologics and China Biologics) are also presented in detail.

Purchase a copy of this “Blood Plasma Market (Immunoglobulin, Albumin, Factor VIII, & Alpha 1)” Report @

Key Target Audience:

  • Blood Plasma Products Manufacturers
  • End Users (Hospitals, Medical Centers & Clinical Institutes)
  • Consulting Firms
  • Investment Banks
  • Government Bodies & Regulating Authorities

Inquire more before buying this report @

About Us provides market research reports to industries, individuals and organizations with an objective of helping them in their decision making process. Our library of 500,000+ industry & country research reports covers 5000+ micro markets.

Connect us @ [email protected] with subject line “Market Research Report on Global Blood Plasma Market “ and your contact details to purchase this report or get your questions answered. OR Call Us @ +1 888 391 5441.

Share This Post